Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M116Revenue (TTM) $M--Net Margin (%)--Altman Z-Score-1.3
Enterprise Value $M40.4EPS (TTM) $-2.2Operating Margin %--Piotroski F-Score2
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book1.410-y EBITDA Growth Rate %--Quick Ratio9.5Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio9.5Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-63.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-82.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M29.8ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with LIFE

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

LIFE is held by these investors:



LIFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MENDLEIN JOHNCEO and Director 2017-08-31Buy37,736$2.6547.17view
SCHIMMEL PAULDirector 2017-08-31Buy94,336$2.6547.17view
MENDLEIN JOHNCEO and Director 2017-04-24Buy124$330view
MENDLEIN JOHNCEO and Director 2017-04-20Buy2,552$330view
SCHIMMEL PAULDirector 2016-12-21Buy25,000$2.2871.05view
Amanullah AshrafVice President, Manufacturing 2016-12-20Buy11,000$2.2573.33view
MENDLEIN JOHNCEO and Director 2016-12-19Buy69,000$2.277.27view
SCHIMMEL PAULDirector 2016-12-16Buy50,000$2.4857.26view
Matsuoka GroveSee Remarks 2016-05-11Buy12,412$3.0428.29view
SCHIMMEL PAULDirector 2016-04-14Buy66,219$4.18-6.7view

Press Releases about LIFE :

Quarterly/Annual Reports about LIFE:

News about LIFE:

Articles On GuruFocus.com
aTyr Pharma Announces Third Quarter 2017 Operating Results and Provides Corporate Update Nov 14 2017 
aTyr Pharma Announces Leadership Transition Nov 01 2017 
Andreas Halvorsen Dives into Deciphera Pharma Oct 12 2017 
aTyr Pharma to Present Final Data for Resolaris Phase 1b/2 Trial in Patients with Early-Onset Facios Sep 27 2017 
aTyr Pharma to Present at Two Upcoming Investor Conferences in September Sep 05 2017 
aTyr Pharma Announces $45 Million Equity Financing Aug 28 2017 
aTyr Pharma Announces Second Quarter 2017 Operating Results and Provides an Update on Innovative Imm Aug 14 2017 
aTyr Pharma Announces Date of Earnings Release For Second Quarter 2017 Financial Results Aug 10 2017 
aTyr Pharma Announces Presentations on Interstitial Lung Disease and the iMod.Fc Program at the Amer May 15 2017 
aTyr Pharma Announces First Quarter 2017 Operating Results May 11 2017 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK